Skip to content
healthcare.dev
Get a free key

INVOKAMET XR

NDC 50458-940, canagliflozin and metformin hydrochloride, tablet, film coated, extended release, from Janssen Pharmaceuticals, Inc..

Product NDC
50458-940
Status
Listed
Labeler
Janssen Pharmaceuticals, Inc.
Dosage form
TABLET, FILM COATED, EXTENDED RELEASE
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
NDA
Application
NDA205879
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/50458-940 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • CANAGLIFLOZIN50 mg/1
  • METFORMIN HYDROCHLORIDE500 mg/1

Pharmacologic classes

Biguanide [EPC]; Biguanides [CS]; P-Glycoprotein Inhibitors [MoA]; Sodium-Glucose Cotransporter 2 Inhibitor [EPC]; Sodium-Glucose Transporter 2 Inhibitors [MoA]

Package NDCNDC-11Package
50458-940-015045809400160 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (50458-940-01)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/6868666b-c25e-40d1-9d1f-306bbe9390c1

  • NADAC price for package 50458094001

    GET /v1/drugs/nadac/50458094001

Use it

Look up 50458-940 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/50458-940 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 50458-940. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Get a free keyNDC docsConnect the MCP server

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.